$4.44
-0.06 (-1.33%)
Open$4.50
Previous Close$4.50
Day High$4.50
Day Low$4.37
52W High$5.12
52W Low$2.44
Volume—
Avg Volume28.5K
Market Cap84.63M
P/E Ratio—
EPS$-2.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+749.3% upside
Current
$4.44
$4.44
Target
$37.71
$37.71
$24.55
$37.71 avg
$48.03
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.69M | 23.13M | 22.16M |
| Net Income | 4.47M | 4.40M | 4.69M |
| Profit Margin | 18.9% | 19.1% | 21.2% |
| EBITDA | 8.95M | 8.70M | 7.31M |
| Free Cash Flow | 3.30M | 3.54M | 2.93M |
| Rev Growth | +11.0% | +7.8% | +15.1% |
| Debt/Equity | 0.08 | 0.09 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |